China Cord Blood (CO) Reports In-Line Q1 EPS

China Cord Blood (NYSE: CO) reported Q1 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $26 million versus the consensus estimate of $26.23 million.

New subscribers and accumulated subscriber base were 16,637 and 520,905, respectively. Gross profit increased by 5.2% to RMB135.5 million ($20.4 million) from RMB128.8 million in the prior year period.

For earnings history and earnings-related data on China Cord Blood (CO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c